Cargando…
Endoscopic palliation of advanced esophageal cancer
Esophageal cancer represents one of the most aggressive digestive tumors, with a survival rate at 5 years of only 10%. Globally, during the last three decades, there has been an increasing incidence of the esophageal cancer, approx. 400,000 new esophageal cancers being currently diagnosed annually....
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Carol Davila University Press
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4392091/ https://www.ncbi.nlm.nih.gov/pubmed/25866578 |
_version_ | 1782365921623408640 |
---|---|
author | Mocanu, A Bârla, R Hoara, P Constantinoiu, S |
author_facet | Mocanu, A Bârla, R Hoara, P Constantinoiu, S |
author_sort | Mocanu, A |
collection | PubMed |
description | Esophageal cancer represents one of the most aggressive digestive tumors, with a survival rate at 5 years of only 10%. Globally, during the last three decades, there has been an increasing incidence of the esophageal cancer, approx. 400,000 new esophageal cancers being currently diagnosed annually. This represents the eighth leading cause of cancer incidence and the sixth leading cause of cancer death overall. Taking into account the population’s global aging and thus, the increase in the number of patients who will not bear surgery, PCT and radiation, or the fact that they do not want it especially because of deficiencies and associated pathology, the endoscopic ablative techniques with palliation purposes represent the alternative. If we refer to the Western Europe countries and North America, we notice an increase of esophageal adenocarcinoma rate versus squamous cancer. As for the Asian region, referring in particular to China and Japan, 9 out of 10 esophageal cancers are squamous cell carcinomas. For at least half of the patients with EC (esophageal cancer) there is no hope of healing because of the advanced regional malignant invasion (T3-4, N+, M+) with no chemo and radiotherapy response, poor preoperative patients’ conditions or systemic metastasis. The low life expectancy does not justify the risky medical procedures, the goal of the therapy consisting in the improvement of the quality of life by eliminating dysphagia (reestablishing oral feeding) which represents the most common complication of EC, the respiratory tract complication caused by eso-tracheal fistulas or by eliminating chest pain. To treat dysphagia, which is the main target of palliation, combined methods like endoscopic, chemo and radio-therapy, can be used, each one with indications, benefits and risks. Abbreviations: SEPS = self expanding plastic stent, SREMS = self expanding metal stent, EBRT = Endoscopic brachy radiotherapy, EUS = Ultra sound endoscopy, CT = Computer tomograph, UGE = Upper gastro endoscopy, PET-CT = Positron Emission Tomography, APC = argon plasma coagulation, PDT = photo dynamic therapy, PCT = Poli-chemotherapy, RT = Radio-therapy |
format | Online Article Text |
id | pubmed-4392091 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | Carol Davila University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-43920912015-06-01 Endoscopic palliation of advanced esophageal cancer Mocanu, A Bârla, R Hoara, P Constantinoiu, S J Med Life General Articles Esophageal cancer represents one of the most aggressive digestive tumors, with a survival rate at 5 years of only 10%. Globally, during the last three decades, there has been an increasing incidence of the esophageal cancer, approx. 400,000 new esophageal cancers being currently diagnosed annually. This represents the eighth leading cause of cancer incidence and the sixth leading cause of cancer death overall. Taking into account the population’s global aging and thus, the increase in the number of patients who will not bear surgery, PCT and radiation, or the fact that they do not want it especially because of deficiencies and associated pathology, the endoscopic ablative techniques with palliation purposes represent the alternative. If we refer to the Western Europe countries and North America, we notice an increase of esophageal adenocarcinoma rate versus squamous cancer. As for the Asian region, referring in particular to China and Japan, 9 out of 10 esophageal cancers are squamous cell carcinomas. For at least half of the patients with EC (esophageal cancer) there is no hope of healing because of the advanced regional malignant invasion (T3-4, N+, M+) with no chemo and radiotherapy response, poor preoperative patients’ conditions or systemic metastasis. The low life expectancy does not justify the risky medical procedures, the goal of the therapy consisting in the improvement of the quality of life by eliminating dysphagia (reestablishing oral feeding) which represents the most common complication of EC, the respiratory tract complication caused by eso-tracheal fistulas or by eliminating chest pain. To treat dysphagia, which is the main target of palliation, combined methods like endoscopic, chemo and radio-therapy, can be used, each one with indications, benefits and risks. Abbreviations: SEPS = self expanding plastic stent, SREMS = self expanding metal stent, EBRT = Endoscopic brachy radiotherapy, EUS = Ultra sound endoscopy, CT = Computer tomograph, UGE = Upper gastro endoscopy, PET-CT = Positron Emission Tomography, APC = argon plasma coagulation, PDT = photo dynamic therapy, PCT = Poli-chemotherapy, RT = Radio-therapy Carol Davila University Press 2015 /pmc/articles/PMC4392091/ /pubmed/25866578 Text en ©Carol Davila University Press http://creativecommons.org/licenses/by/2.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | General Articles Mocanu, A Bârla, R Hoara, P Constantinoiu, S Endoscopic palliation of advanced esophageal cancer |
title | Endoscopic palliation of advanced esophageal cancer
|
title_full | Endoscopic palliation of advanced esophageal cancer
|
title_fullStr | Endoscopic palliation of advanced esophageal cancer
|
title_full_unstemmed | Endoscopic palliation of advanced esophageal cancer
|
title_short | Endoscopic palliation of advanced esophageal cancer
|
title_sort | endoscopic palliation of advanced esophageal cancer |
topic | General Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4392091/ https://www.ncbi.nlm.nih.gov/pubmed/25866578 |
work_keys_str_mv | AT mocanua endoscopicpalliationofadvancedesophagealcancer AT barlar endoscopicpalliationofadvancedesophagealcancer AT hoarap endoscopicpalliationofadvancedesophagealcancer AT constantinoius endoscopicpalliationofadvancedesophagealcancer |